These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8835000)

  • 1. [Therapy of Sézary syndrome by extracorporeal photochemotherapy].
    Bohmeyer J; Otte HG; Stadler R
    Hautarzt; 1996 Jan; 47(1):24-8. PubMed ID: 8835000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P; Fierro MT; Rossotto GL; Savoia P; Bernengo MG
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoidal tissue reaction in Sézary syndrome.
    Gregg PJ; Kantor GR; Telang GH; Lessin SR; Nowell PC; Vonderheid EC
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):372-6. PubMed ID: 10901727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
    Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
    J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.
    Fraser-Andrews E; Seed P; Whittaker S; Russell-Jones R
    Arch Dermatol; 1998 Aug; 134(8):1001-5. PubMed ID: 9722731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of insulin-dependent diabetes mellitus on response to extracorporeal photopheresis in patients with Sézary syndrome.
    Bouwhuis SA; el-Azhary RA; Gibson LE; McEvoy MT; Pittelkow MR
    J Am Acad Dermatol; 2002 Jul; 47(1):63-7. PubMed ID: 12077583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemotherapy of Sézary syndrome.
    Kövary PM; Frosch P; Macher E
    Dermatologica; 1981; 162(2):112-7. PubMed ID: 7018942
    [No Abstract]   [Full Text] [Related]  

  • 9. Sézary syndrome and seronegative polyarthritis: treatment with extracorporeal photochemotherapy.
    Macheiner W; Jantschitsch C; Graninger W; Pálóczy K; Bálint G; Marschalkó M; Kainberger F; Breier F; Knobler RM
    J Am Acad Dermatol; 2003 Feb; 48(2):220-6. PubMed ID: 12582392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone.
    Trotter MJ; Whittaker SJ; Orchard GE; Smith NP
    J Cutan Pathol; 1997 May; 24(5):286-91. PubMed ID: 9194581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis and adjuvant aerosolized granulocyte-macrophage colony-stimulating factor for Sézary syndrome.
    Bouwhuis SA; Markovic SN; McEvoy MT; Pittelkow MR
    Mayo Clin Proc; 2002 Feb; 77(2):197-200. PubMed ID: 11838656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of erythrodermic-CTCL.
    Shimoda T; Aoki M; Takezaki S; Futagami A; Inokuchi K; Sugisaki Y; Kawana S
    Leuk Lymphoma; 2006 Aug; 47(8):1708-10. PubMed ID: 16966295
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sézary cell counts in treatment of the Sézary syndrome.
    Zackheim HS
    J Am Acad Dermatol; 1991 Oct; 25(4):731-2. PubMed ID: 1791233
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined therapy for Sézary syndrome with extracorporeal photochemotherapy and low-dose interferon alfa therapy. Clinical, molecular, and immunologic observations.
    Rook AH; Prystowsky MB; Cassin M; Boufal M; Lessin SR
    Arch Dermatol; 1991 Oct; 127(10):1535-40. PubMed ID: 1929461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
    Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG
    Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of Sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis.
    Stevens SR; Baron ED; Masten S; Cooper KD
    Arch Dermatol; 2002 Oct; 138(10):1347-50. PubMed ID: 12374541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photochemotherapy--the Columbia Presbyterian experience.
    Knobler E; Warmuth I; Cocco C; Miller B; Mackay J
    Photodermatol Photoimmunol Photomed; 2002 Oct; 18(5):232-7. PubMed ID: 12390664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteonecrosis of the Jaw in Association With Chemotherapy in the Setting of Cutaneous T-Cell Lymphoma.
    DeSesa CR; Appugounder S; Haberland C; Johnson MP
    J Oral Maxillofac Surg; 2016 Feb; 74(2):292-301. PubMed ID: 26296596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.